Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system
Article in Expert Opinion on Drug Safety (May 2024)
The most recent citing publications are shown below. View all 152 publications that cite this research output on Dimensions.
Article in Expert Opinion on Drug Safety (May 2024)
Article in Internal Medicine (May 2024)
Article in Cochrane Database of Systematic Reviews (April 2024)